Optimizing Rare Disease Clinical Trials Through Patient Experience
Why Collaboration with the Rare Disease Community is Vital to Today’s Research
Improve Study Success & Patient Experience
Leverage the Power of Partnership in Your Next Trial
Clinical trials are pivotal in advancing medical research and developing treatments for rare diseases. However, an alarming 80% of trials fail to conclude on schedule, creating significant hurdles for affected patients and communities.
With an emphasis on clinical transparency, collaboration, and data privacy, our webinar provides a unique opportunity to better understand and address the challenges inherent in rare disease clinical trials to drive innovation and improve lives.
Hear From
Industry Expert Panelists
![Pam-Cusick-150](https://www.scoutclinical.com/hs-fs/hubfs/Pam-Cusick-150.webp?width=60&height=60&name=Pam-Cusick-150.webp)
SVP, Rare Patient Voice
![Monica-150](https://www.scoutclinical.com/hs-fs/hubfs/Monica-150.webp?width=60&height=60&name=Monica-150.webp)
Founder, SYNGAP1 Foundation
![Kimberlee_Heidmann-150](https://www.scoutclinical.com/hs-fs/hubfs/Kimberlee_Heidmann-150.webp?width=60&height=60&name=Kimberlee_Heidmann-150.webp)
EVP of Patient Experience and Customer Success, Scout
Moderated by Kuno van der Post
Chief Revenue Officer, Scout
Get Their
Rare Disease Research Insights
This discussion covers topics including:
-
Challenges to rare disease trial success
-
Effects on rare disease patients, families and caregivers
-
The importance of patient experience (and how to enhance it)
-
Partnering with rare disease communities and advocacy groups